The long-term efficacy of antihypertensive therapy with losartan in childhood to reduce cardiovascular morbidity and mortality has also not been established.
Kindlaks ei ole tehtud ka losartaanravi pikaajaline efektiivsus kardiovaskulaarse haigestumuse ja suremuse vähendamisel lapseeas.